162 related articles for article (PubMed ID: 7439991)
21. Opposite effects of the synthetic adjuvant N-acetyl-muramyl-L-alanyl-D-isoglutamine on the immune response in mice depending on experimental conditions.
Souvannavong V; Adam A
Eur J Immunol; 1980 Aug; 10(8):654-6. PubMed ID: 6995138
[TBL] [Abstract][Full Text] [Related]
22. Effects of treatment with muramyl dipeptide on resistance to Mycobacterium leprae and Mycobacterium marinum infection in mice.
Krahenbuhl JL; Humphres RC
Immunopharmacology; 1983 Apr; 5(4):329-39. PubMed ID: 6343295
[TBL] [Abstract][Full Text] [Related]
23. Immunoadjuvant activity of synthetic N-acetyl muramyl dipeptide.
Masek K; Zaoral M; Jezek J; Straka R
Experientia; 1978 Oct; 34(10):1363-4. PubMed ID: 738426
[No Abstract] [Full Text] [Related]
24. Epithelioid granuloma formation by a synthetic bacterial cell wall component, muramyl dipeptide (MDP).
Tanaka A; Emori K
Am J Pathol; 1980 Mar; 98(3):733-48. PubMed ID: 6767407
[TBL] [Abstract][Full Text] [Related]
25. Stimulation of the reticuloendothelial system of mice by muramyl dipeptide.
Tanaka A; Nagao S; Nagao R; Kotani S; Shiba T; Kusumoto S
Infect Immun; 1979 May; 24(2):302-7. PubMed ID: 457275
[TBL] [Abstract][Full Text] [Related]
26. Comparison of muramyl dipeptide, trehalose dimycolate, and dimethyl dioctadecyl ammonium bromide as adjuvants in Brucella abortus 45/20 vaccines.
Woodard LF; Toone NM; McLaughlin CA
Infect Immun; 1980 Nov; 30(2):409-12. PubMed ID: 6777304
[TBL] [Abstract][Full Text] [Related]
27. Effect of indomethacin on increased resistance to bacterial infection and on febrile responses induced by muramyl dipeptide.
Parant M; Riveau G; Parant F; Dinarello CA; Wolff SM; Chedid L
J Infect Dis; 1980 Nov; 142(5):708-15. PubMed ID: 7462686
[TBL] [Abstract][Full Text] [Related]
28. Enhancing effect of Salmonella enteritidis SPA on nonspecific resistance.
Uchiya K; Sugihara H
Kansenshogaku Zasshi; 1989 May; 63(5):463-70. PubMed ID: 2550565
[TBL] [Abstract][Full Text] [Related]
29. Correlation between in vivo anti-Pseudomonas and anti-Candida activities and clearance of carbon by the reticuloendothelial system for various muramyl dipeptide analogs, using normal and immunosuppressed mice.
Fraser-Smith EB; Waters RV; Matthews TR
Infect Immun; 1982 Jan; 35(1):105-10. PubMed ID: 7054119
[TBL] [Abstract][Full Text] [Related]
30. Enhancement of host resistance against Trypanosoma cruzi infection by the immunoregulatory agent muramyl dipeptide.
Kireszenbaum F; Ferraresi RW
Infect Immun; 1979 Jul; 25(1):273-8. PubMed ID: 113344
[TBL] [Abstract][Full Text] [Related]
31. Efficient genetically controlled formation of antibody to a synthetic antigen [poly(LTyr, LGlu)-poly(DLAla)- -poly(LLys)] covalently bound to a synthetic adjuvant (N-acetylmuramyl-L-alanyl-D-isoglutamine).
Mozes E; Sela M; Chedid L
Proc Natl Acad Sci U S A; 1980 Aug; 77(8):4933-7. PubMed ID: 6776530
[TBL] [Abstract][Full Text] [Related]
32. In vivo and in vitro stimulation of nonspecific immunity by the beta-D-p-aminophenyl glycoside of N-acetylmuramyl-L-alanyl-D-isoglutamine and an oligomer prepared by cross-linking with glutaraldehyde.
Parant M; Damais C; Audibert F; Parant F; Chedid L; Sache E; Lefrancier P; Choay J; Lederer E
J Infect Dis; 1978 Sep; 138(3):378-86. PubMed ID: 100563
[TBL] [Abstract][Full Text] [Related]
33. Enhancement of certain biological activities of muramyl dipeptide derivatives after conjugation to a multi-poly(DL-alanine)--poly(L-lysine) carrier.
Chedid L; Parant M; Parant F; Audibert F; Lefrancier F; Choay J; Sela M
Proc Natl Acad Sci U S A; 1979 Dec; 76(12):6557-61. PubMed ID: 293743
[TBL] [Abstract][Full Text] [Related]
34. Adjuvant activity of carbohydrate analogs of N-acetylmuramyl-L-alanyl-D-isoglutamine on the induction of delayed-type hypersensitivity to azobenzenearsonate-N-acetyl-L-tyrosine in guinea pigs.
Azuma I; Okumura H; Saiki I; Kiso M; Hasegawa A; Tanio Y; Yamamura Y
Infect Immun; 1981 Sep; 33(3):834-9. PubMed ID: 7287186
[TBL] [Abstract][Full Text] [Related]
35. Lipophilic derivative of muramyl dipeptide is more active than muramyl dipeptide in priming macrophages to release superoxide anion.
Pabst MJ; Cummings NP; Shiba T; Kusumoto S; Kotani S
Infect Immun; 1980 Aug; 29(2):617-22. PubMed ID: 6260655
[TBL] [Abstract][Full Text] [Related]
36. Influence of a synthetic adjuvant (MDP) on qualitative and quantitative changes of serum globulins.
Leclerc C; Audibert F; Chedid L
Immunology; 1978 Dec; 35(6):963-70. PubMed ID: 738768
[TBL] [Abstract][Full Text] [Related]
37. Analysis of the antigenic relationship of various derivatives of n-acetyl-muramyl-l-ala-d-isoglutamine (MDP), using anti-MDP antibodies.
Bahr GM; Carelli C; Audibert F; Modabber F; Chedid L
Mol Immunol; 1982 May; 19(5):737-45. PubMed ID: 7110143
[TBL] [Abstract][Full Text] [Related]
38. In vitro spleen cell responsiveness to various analogs of MDP (N-acetylmuramyl-L-alanyl-D-isoglutamine), a synthetic immunoadjuvant, in MDP high-responder mice.
Damais C; Parant M; Chedid L; Lefrancier P; Choay J
Cell Immunol; 1978 Jan; 35(1):173-9. PubMed ID: 563773
[No Abstract] [Full Text] [Related]
39. Protective effect of neoglycoprotein-conjugated muramyl dipeptide against Leishmania donovani infection: the role of cytokines.
Sarkar K; Das PK
J Immunol; 1997 Jun; 158(11):5357-65. PubMed ID: 9164956
[TBL] [Abstract][Full Text] [Related]
40. Activation of mouse peritoneal adherent cells with N-acyl muramyl dipeptide derivatives.
Nishimura K; Okumura H; Saiki I; Okuyama H; Azuma I
Infect Immun; 1985 Mar; 47(3):665-9. PubMed ID: 3882562
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
